✦ LIBER ✦

HCV quasispecies evolution during treatment with interferon alfa-2b and ribavirin in two children coinfected with HCV and HIV-1

✍ Scribed by Mathieu Quesnel-Vallières; Mireille Lemay; Normand Lapointe; Steven R. Martin; Hugo Soudeyns

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HCV Treatment with Pegylated Interferon

✍ Denholm, J.T.; Wright, E.J.; Street, A.; Sasadeusz, J.J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Blood Transaminase Elevation with Pegyla

✍ E. Guitton; K. Barange; H. Bagheri; J. L. Montastruc; J. P. Vinel; S. Claeyssens 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 244 KB

Very early prediction of response to HCV

✍ E. S. A. Araújo; H. Dahari; A. U. Neumann; N. de Paula Cavalheiro; C. E. Melo; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

Predictors for Hematopoietic Growth Fact

✍ Pau, Alice K; McLaughlin, Mary M.; Hu, Zonghui; Agyemang, Amma F.; Polis, Michae 📂 Article 📅 2006 🏛 Mary Ann Liebert 🌐 English ⚖ 209 KB

1008 PEG-interferon alfa-2B and ribaviri

✍ STEIN, D; MCKENZIE, S 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Early ribavirin pharmacokinetics, HCV RN

✍ Harel Dahari; Marianthi Markatou; Marija Zeremski; Ivan Haller; Ruy M. Ribeiro; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 243 KB